Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 303298, 7 pages
http://dx.doi.org/10.1155/2014/303298
Review Article

Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy

Department of Emergency and Organ Transplantation, Urology, Andrology and Kidney Transplantation Unit, University of Bari, 70124 Bari, Italy

Received 17 April 2014; Accepted 16 May 2014; Published 2 July 2014

Academic Editor: Giuseppe Grandaliano

Copyright © 2014 Giuseppe Lucarelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Chevalier, B. A. Thornhill, M. S. Forbes, and S. C. Kiley, “Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy,” Pediatric Nephrology, vol. 25, no. 4, pp. 687–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Quinlan, N. G. Docherty, R. W. G. Watson, and J. M. Fitzpatrick, “Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction,” The American Journal of Physiology—Renal Physiology, vol. 295, no. 1, pp. F1–F11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. B. D. Matthews, D. R. Overby, R. Mannix, and D. E. Ingber, “Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels,” Journal of Cell Science, vol. 119, no. 3, pp. 508–518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Goel, W. G. Sinkins, C. D. Zuo, M. Estacion, and W. P. Schilling, “Identification and localization of TRPC channels in the rat kidney,” American Journal of Physiology—Renal Physiology, vol. 290, no. 5, pp. F1241–F1252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Rohatgi and D. Flores, “Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney,” Current Opinion in Nephrology and Hypertension, vol. 19, no. 1, pp. 65–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Mezzano, M. Ruiz-Ortega, and J. Egido, “Angiotensin II and renal fibrosis,” Hypertension, vol. 38, no. 3, part 2, pp. 635–638, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Rüster and G. Wolf, “Renin-angiotensin-aldosterone system and progression of renal disease,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 2985–2991, 2006. View at Publisher · View at Google Scholar
  8. J. J. Morrissey, S. Ishidoya, R. McCracken, and S. Klahr, “Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy,” Journal of the American Society of Nephrology, vol. 7, no. 10, pp. 2202–2212, 1996. View at Google Scholar · View at Scopus
  9. D. Felsen, D. Schulsinger, S. S. Gross, F. Y. Kim, D. Marion, and E. D. Vaughan Jr., “Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide,” Journal of Urology, vol. 169, no. 1, pp. 373–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Felsen, K. Dardashti, M. Ostad et al., “Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction,” Journal of Urology, vol. 169, no. 4, pp. 1569–1572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Brasier and J. Li, “Mechanisms for inducible control of angiotensinogen gene transcription,” Hypertension, vol. 27, no. 3, part 2, pp. 465–475, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Li and A. R. Brasier, “Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (nuclear factor-κB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes,” Molecular Endocrinology, vol. 10, no. 3, pp. 252–264, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Zhang, S. D. Oldroyd, L. H. Huang et al., “Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy,” Experimental Nephrology, vol. 9, no. 2, pp. 71–80, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. G. Docherty, O. E. O'Sullivan, D. A. Healy, J. M. Fitzpatrick, and R. W. G. Watson, “Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction,” The American Journal of Physiology— Renal Physiology, vol. 290, no. 1, pp. F4–F13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Liu, “New insights into epithelial-mesenchymal transition in kidney fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Grandaliano, L. Gesualdo, F. Bartoli et al., “MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy,” Kidney International, vol. 58, no. 1, pp. 182–192, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Bartoli, R. Penza, G. Aceto et al., “Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction,” Journal of Pediatric Surgery, vol. 46, no. 3, pp. 530–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Segerer, P. J. Nelson, and D. Schlöndorff, “Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 152–176, 2000. View at Google Scholar · View at Scopus
  19. G. Grandaliano, L. Gesualdo, E. Ranieri et al., “Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment,” Journal of the American Society of Nephrology, vol. 7, no. 6, pp. 906–913, 1996. View at Google Scholar · View at Scopus
  20. J. R. Diamond, D. Kees-Folts, J. E. Frye, and N. C. Restrepo, “Macrophages, monocyte chemoattractant peptide-1, and TGF-beta1 in experimental hydronephrosis,” American Journal of Physiology, vol. 266, no. 6, pp. F926–F933, 1994. View at Google Scholar · View at Scopus
  21. K. S. Eardley, D. Zehnder, M. Quinkler et al., “The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease,” Kidney International, vol. 69, no. 7, pp. 1189–1197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Ma, H. Yang, A. Gaspert et al., “Transforming growth factor-β-dependent and -independent pathways of induction of tubulointerstitial fibrosis in β6(-/-) mice,” The American Journal of Pathology, vol. 163, no. 4, pp. 1261–1273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sato, Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima, “Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction,” Journal of Clinical Investigation, vol. 112, no. 10, pp. 1486–1494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Misseri, D. R. Meldrum, C. A. Dinarello et al., “TNF-α mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling,” The American Journal of Physiology: Renal Physiology, vol. 288, no. 2, pp. F406–F411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gesualdo, S. Di Paolo, A. Calabró et al., “Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study,” Kidney International, vol. 49, no. 3, pp. 656–665, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Storch, S. Saggi, J. Megyesi, P. M. Price, and R. Safirstein, “Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression,” Kidney International, vol. 42, no. 1, pp. 89–94, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. H. D. Humes, D. A. Cieslinski, T. M. Coimbra, J. M. Messana, and C. Galvao, “Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure,” Journal of Clinical Investigation, vol. 84, no. 6, pp. 1757–1761, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. W. A. Kennedy II, R. Buttyan, E. Garcia-Montes, C. A. Olsson, and I. S. Sawczuk, “Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction,” Urology, vol. 49, no. 6, pp. 973–980, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. D. D. Torres, M. Rossini, C. Manno et al., “The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy,” Kidney International, vol. 73, no. 3, pp. 327–333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. L. Chevalier, A. Kim, B. A. Thornhill, and J. T. Wolstenholme, “Recovery following relief of unilateral ureteral obstruction in the neonatal rat,” Kidney International, vol. 55, no. 3, pp. 793–807, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. R. L. Chevalier, B. A. Thornhill, and A. Y. Chang, “Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood,” Kidney International, vol. 58, no. 5, pp. 1987–1995, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Ito, J. Chen, M. El Chaar et al., “Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats,” The American Journal of Physiology—Renal Physiology, vol. 287, no. 6, pp. F1283–F1293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Lucarelli, P. Ditonno, C. Bettocchi et al., “Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury,” Journal of Urology, vol. 189, no. 3, pp. 960–965, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Bartoli, L. Gesualdo, G. Paradies et al., “Renal expression of monocyte chemotactic protein-1 and epidermal growth factor in children with obstructive hydronephrosis,” Journal of Pediatric Surgery, vol. 35, no. 4, pp. 569–572, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Chertin, A. Farkas, and P. Puri, “Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy,” European Urology, vol. 44, no. 1, pp. 144–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Munshi, A. Johnson, E. D. Siew et al., “MCP-1 gene activation marks acute kidney injury,” Journal of the American Society of Nephrology, vol. 22, no. 1, pp. 165–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. R. Flower, “The lipocalin protein family: structure and function,” Biochemical Journal, vol. 318, part 1, pp. 1–14, 1996. View at Google Scholar · View at Scopus
  38. J. Mishra, M. A. Qing, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. M. Schmidt-Ott, K. Mori, Y. L. Jau et al., “Dual action of neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 407–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. T. L. Nickolas, M. J. O'Rourke, J. Yang et al., “Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury,” Annals of Internal Medicine, vol. 148, no. 11, pp. 810–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Kuwabara, K. Mori, M. Mukoyama et al., “Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons,” Kidney International, vol. 75, no. 3, pp. 285–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Ding, Y. He, K. Li et al., “Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy,” Clinical Immunology, vol. 123, no. 2, pp. 227–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Noto, F. Cibecchini, V. Fanos, and M. Mussap, “NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury,” BioMed Research International, vol. 2013, Article ID 612032, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Haase-Fielitz, M. Haase, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status,” Annals of Clinical Biochemistry, vol. 51, part 3, pp. 335–351, 2014. View at Google Scholar
  45. A. Wasilewska, K. Taranta-Janusz, W. Dȩbek, W. Zoch-Zwierz, and E. Kuroczycka-Saniutycz, “KIM-1 and NGAL: new markers of obstructive nephropathy,” Pediatric Nephrology, vol. 26, no. 4, pp. 579–586, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. N. G. Cost, P. H. Noh, P. Devarajan et al., “Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty,” Journal of Urology, vol. 190, no. 4, supplement, pp. 1462–1467, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. I. Lim, S. C. W. Tang, K. N. Lai, and J. C. K. Leung, “Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?” Journal of Cellular Physiology, vol. 228, no. 5, pp. 917–924, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, “Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury,” Kidney International, vol. 62, no. 1, pp. 237–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. W. K. Han, G. Wagener, Y. Zhu, S. Wang, and H. T. Lee, “Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 873–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Liangos, M. C. Perianayagam, V. S. Vaidya et al., “Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure,” Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 904–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. M. van Timmeren, M. C. van den Heuvel, V. Bailly, S. J. L. Bakker, H. van Goor, and C. A. Stegeman, “Tubular kidney injury molecule-1 (KIM-1) in human renal disease,” Journal of Pathology, vol. 212, no. 2, pp. 209–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. M. Van Timmeren, V. S. Vaidya, R. M. Van Ree et al., “High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients,” Transplantation, vol. 84, no. 12, pp. 1625–1630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. P. L. Zhang, L. I. Rothblum, W. K. Han, T. M. Blasick, S. Potdar, and J. V. Bonventre, “Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury,” Kidney International, vol. 73, no. 5, pp. 608–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Szeto, B. C. Kwan, K. Lai et al., “Urinary expression of kidney injury markers in renal transplant recipients,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2329–2337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Lucarelli, C. Bettocchi, M. Battaglia et al., “Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years,” Transplantation Proceedings, vol. 42, no. 4, pp. 1104–1107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. V. Impedovo, E. De Lorenzis, A. Volpe et al., “Middle and long-term outcomes of dual kidney transplant: a multicenter experience,” Transplantation Proceedings, vol. 45, no. 3, pp. 1237–1241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Lucarelli, M. Fanelli, A. M. V. Larocca et al., “Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/mL,” Prostate, vol. 72, no. 15, pp. 1611–1621, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Lucarelli, P. Ditonno, C. Bettocchi et al., “Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer,” Future Oncology, vol. 9, no. 6, pp. 899–907, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Lucarelli, M. Rutigliano, C. Bettocchi et al., “Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer,” Journal of Urology, vol. 190, no. 6, pp. 2271–2277, 2013. View at Publisher · View at Google Scholar
  60. G. Lucarelli, P. Ditonno, C. Bettocchi et al., “Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma,” Disease Markers, vol. 2014, Article ID 689795, 9 pages, 2014. View at Publisher · View at Google Scholar
  61. W. K. Han, A. Alinani, C. L. Wu et al., “Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma,” Journal of the American Society of Nephrology, vol. 16, no. 4, pp. 1126–1134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Xue, Y. Xie, Q. Wang et al., “Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase -associated lipocalin for acute kidney injury in an obstructive nephropathy patient,” Nephrology, vol. 19, no. 4, pp. 186–194, 2014. View at Publisher · View at Google Scholar